| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/13/2007 | WO2007140906A1 Use of leucyl/cystinyl aminopeptidase (lnpep) as a therapeutic or diagnostic target |
| 12/13/2007 | WO2007140545A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefore |
| 12/13/2007 | WO2007140534A1 Vegf-a cross-reactive anti- vegf-b antibodies as antagonists of vegf-a and vegf-b signalling |
| 12/13/2007 | WO2007140505A2 Vaccine carrier |
| 12/13/2007 | WO2007118660A3 Her-2/neu multi-peptide vaccine |
| 12/13/2007 | WO2007112410A8 Tolerizing agents |
| 12/13/2007 | WO2007109564A3 Yeast cell particles as oral delivery vehicles for antigens |
| 12/13/2007 | WO2007108559A8 Agonistic antibody directed against human thrombopoietin receptor |
| 12/13/2007 | WO2007106415A9 Triggered self-assembly conjugates and nanosystems |
| 12/13/2007 | WO2007104529A3 Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
| 12/13/2007 | WO2007098924A3 Composition comprising an agent for stabilizing active substances in drinking water, effervescent mixture, method for the production thereof, and use thereof |
| 12/13/2007 | WO2007095616A3 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain |
| 12/13/2007 | WO2007084105A3 Modulation of fc gamma receptors for optimizing immunotherapy |
| 12/13/2007 | WO2007065433A3 Anti-orthopoxvirus recombinant polyclonal antibody |
| 12/13/2007 | WO2007041285A3 Complexes of inactivated pepsin fraction and heat shock protein |
| 12/13/2007 | WO2007037795A3 Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| 12/13/2007 | WO2007030820A3 Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists |
| 12/13/2007 | WO2007030778A3 Universal rapid test and method for detection of tuberculosis in multiple host species |
| 12/13/2007 | WO2006138737A8 Methods of purifying anti a beta antibodies |
| 12/13/2007 | WO2006130374A3 Tweak binding antibodies |
| 12/13/2007 | WO2006127517A9 Pretreatment of a biological sample from an autoimmune disease subject |
| 12/13/2007 | WO2006123256A8 Hivcon: an hiv immunogen and uses thereof |
| 12/13/2007 | WO2006115548A3 Subunit vaccine against west nile viral infection |
| 12/13/2007 | WO2006052660A3 Il-7 receptor blockade to suppress immunity |
| 12/13/2007 | WO2005113019A3 Methods for the treatment of autoimmune diseases |
| 12/13/2007 | WO2004015390A3 Lung cancer target proteins and use thereof |
| 12/13/2007 | WO2003101600A3 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion |
| 12/13/2007 | US20070289029 Means and Methods for Producing a Stabilized Cell of Interest |
| 12/13/2007 | US20070287970 Method for systemic drug delivery through the nail |
| 12/13/2007 | US20070287682 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070286896 Therapeutic or Diagnostic Drug for Inflammatory Disease Comprising Targeting Liposome |
| 12/13/2007 | US20070286874 Recombinant attenuated clostridium organisms and vaccine |
| 12/13/2007 | US20070286873 Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor |
| 12/13/2007 | US20070286872 Live Attenuated Nidovirus Vaccines |
| 12/13/2007 | US20070286871 Vaccines |
| 12/13/2007 | US20070286870 Modified Vp1-Capsid Protein Of Parvovirus B19 |
| 12/13/2007 | US20070286869 Influenza virus vaccine composition and methods of use |
| 12/13/2007 | US20070286868 Phosphorylcholine Conjugates and Corresponding Antibodies |
| 12/13/2007 | US20070286867 Combination Therapy |
| 12/13/2007 | US20070286866 Compositions For Reducing Bacterial Carriage And Cnc Invasion And Methods Of Using Same |
| 12/13/2007 | US20070286865 Use of HE4 and other biochemical markers for assessment of ovarian cancers |
| 12/13/2007 | US20070286864 Treating non-small cell lung cancer (NSCLC), pancreatic, colon or breast cancer tumors or tumor metastases; using erlotinib HCl (also known as TARCEVA); 3-Phosphoinositide-dependent protein kinase 1 (PDK1) inhibitor |
| 12/13/2007 | US20070286863 CMKLR regulation of adipogenesis and adipocyte metabolic function |
| 12/13/2007 | US20070286862 Cancer Associated Antigens |
| 12/13/2007 | US20070286861 Therapeutic antibody specific for oncostatin M for use in treatment and diagnosis of rheumatoid arthritis, juvenile onset arthritis or osteoarthritis |
| 12/13/2007 | US20070286860 Compositions and Methods for Inducing Anti-Tumor Immunity |
| 12/13/2007 | US20070286859 Fc Variants Having Decreased Affinity for FcyRl |
| 12/13/2007 | US20070286858 Methods and Compositions for Antagonism of RAGE |
| 12/13/2007 | US20070286857 Anti-Cd52 Antibody Treatment for Diabetes |
| 12/13/2007 | US20070286856 Enzyme is a drug target; cancer, inflammatory diseases such as psoriasis |
| 12/13/2007 | US20070286855 Improving treatments |
| 12/13/2007 | US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard) |
| 12/13/2007 | US20070286852 Sppls as Modifiers of the P53 Pathway and Methods of Use |
| 12/13/2007 | US20070286807 Method Of Inducing Or Modulating Immune Response |
| 12/13/2007 | CA2657971A1 Vaccine carrier |
| 12/13/2007 | CA2656583A1 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 12/13/2007 | CA2656560A1 A novel virulence determinant within the e2 structural glycoprotein of classical swine fever virus |
| 12/13/2007 | CA2654712A1 Human binding molecules having killing activity against staphylococci and uses thereof |
| 12/13/2007 | CA2654623A1 An anti-nr10/il-31ra antibody for use in preventing or treating an inflammatory disease |
| 12/13/2007 | CA2654572A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 12/13/2007 | CA2654502A1 Human binding molecules having killing activity against enterococci and uses thereof |
| 12/13/2007 | CA2654330A1 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma |
| 12/13/2007 | CA2654324A1 Hiv-1 clade a consensus sequences, antigens, and transgenes |
| 12/13/2007 | CA2654304A1 Compositions and methods for modulating vascular development |
| 12/13/2007 | CA2654025A1 Hepatocyte growth factor (hgf) binding proteins |
| 12/13/2007 | CA2654019A1 Hepatocyte growth factor (hgf) binding proteins |
| 12/13/2007 | CA2653444A1 Blood-brain barrier targeting antibodies |
| 12/13/2007 | CA2652999A1 Methods, compositions, and kits for treating shiga toxin associated conditions |
| 12/13/2007 | CA2652976A1 High affinity antibodies to human il-6 receptor |
| 12/13/2007 | CA2652228A1 Myxoma virus mutants for cancer treatment |
| 12/13/2007 | CA2652222A1 Preparation of antibody- or antibody-fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| 12/13/2007 | CA2636288A1 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
| 12/13/2007 | CA2626082A1 Methods and compositions for use in treatment of patients with autoantibody positive disease |
| 12/13/2007 | CA2589393A1 Ligand for g-protein coupled receptor gpr72 and uses thereof |
| 12/12/2007 | EP1865066A2 Genetic immunisation against cervical carcinoma |
| 12/12/2007 | EP1865065A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/12/2007 | EP1865062A2 Altered OspA of Borrelia burgdorferi |
| 12/12/2007 | EP1865058A1 Anti-cd-20 monoclonal antibody |
| 12/12/2007 | EP1865055A1 Component of bromelain |
| 12/12/2007 | EP1865001A1 Specific protease inhibitors and their use in cancer therapy |
| 12/12/2007 | EP1864997A1 ROR ALPHA PROMOTING THE INDUCTION OF Bmal1 EXPRESSION |
| 12/12/2007 | EP1864996A1 Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker. |
| 12/12/2007 | EP1864981A1 Thrombopoietin mimetics |
| 12/12/2007 | EP1864691A1 Modified CEA nucleic acid and expression vectors |
| 12/12/2007 | EP1864679A2 Improved bacterial outer membrane vesicles |
| 12/12/2007 | EP1864676A1 Antigenic modification of polypeptides |
| 12/12/2007 | EP1864134A2 Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| 12/12/2007 | EP1864131A2 Natural ligand of g protein coupled receptor rcc356 and uses thereof |
| 12/12/2007 | EP1863940A2 Method of risk management for patients undergoing natalizumab treatment |
| 12/12/2007 | EP1863914A1 Tuberculosis vaccine and method for making same |
| 12/12/2007 | EP1863906A1 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 12/12/2007 | EP1863848A2 Antibodies and related molecules that bind to 161p2f10b proteins |
| 12/12/2007 | EP1863846A2 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses |
| 12/12/2007 | EP1863845A2 Antibodies against candida antigens |
| 12/12/2007 | EP1863844A1 Heterodimeric protein binding compositions |
| 12/12/2007 | EP1863835A2 Vaccine and antibodies against parasitic nematodes |
| 12/12/2007 | EP1863536A1 Synthetic anti-candida albicans oligosaccharide based vaccines |
| 12/12/2007 | EP1863532A1 Anti-ctla4 antibody and indolinone combination therapy for treatment of cancer |
| 12/12/2007 | EP1863531A1 Improvements in or relating to treatment and prevention of viral infections |